Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$1.73 - $4.07 $4,337 - $10,203
2,507 New
2,507 $10,000
Q2 2023

Aug 10, 2023

BUY
$3.5 - $5.67 $9,310 - $15,082
2,660 New
2,660 $14,000
Q4 2022

Jun 14, 2023

BUY
$3.66 - $6.77 $11,225 - $20,763
3,067 New
3,067 $12.1 Million
Q4 2022

Mar 30, 2023

BUY
$3.66 - $6.77 $7,795 - $14,420
2,130 Added 227.32%
3,067 $12,000
Q4 2022

Feb 15, 2023

BUY
$3.66 - $6.77 $7,795 - $14,420
2,130 Added 227.32%
3,067 $12,000
Q3 2022

Jun 14, 2023

BUY
$4.68 - $8.34 $4,385 - $7,814
937 New
937 $4.98 Million
Q3 2022

Mar 30, 2023

SELL
$4.68 - $8.34 $9,870 - $17,589
-2,109 Reduced 69.24%
937 $4,000
Q3 2022

Nov 14, 2022

SELL
$4.68 - $8.34 $9,870 - $17,589
-2,109 Reduced 69.24%
937 $5,000
Q2 2022

Jun 20, 2023

BUY
$4.87 - $9.41 $14,834 - $28,662
3,046 New
3,046 $19,000
Q1 2022

Jun 20, 2023

BUY
$4.16 - $7.76 $12,671 - $23,636
3,046 New
3,046 $22,000
Q1 2022

Mar 30, 2023

SELL
$4.16 - $7.76 $29,456 - $54,948
-7,081 Reduced 69.92%
3,046 $22,000
Q1 2022

May 12, 2022

SELL
$4.16 - $7.76 $29,456 - $54,948
-7,081 Reduced 69.92%
3,046 $22,000
Q4 2021

Jun 21, 2023

BUY
$5.99 - $24.97 $60,660 - $252,871
10,127 New
10,127 $71,000
Q4 2021

Mar 30, 2023

SELL
$5.99 - $24.97 $11,117 - $46,344
-1,856 Reduced 15.49%
10,127 $71,000
Q4 2021

Feb 15, 2022

SELL
$5.99 - $24.97 $11,117 - $46,344
-1,856 Reduced 15.49%
10,127 $72,000
Q3 2021

Jun 21, 2023

BUY
$20.0 - $27.43 $239,660 - $328,693
11,983 New
11,983 $300,000
Q2 2021

Mar 30, 2023

BUY
$24.34 - $38.34 $14,068 - $22,160
578 Added 5.07%
11,983 $322,000
Q2 2021

Aug 16, 2021

BUY
$24.34 - $38.34 $291,398 - $459,006
11,972 Added 108836.36%
11,983 $322,000
Q1 2021

Jun 26, 2023

BUY
$24.74 - $40.2 $282,159 - $458,481
11,405 New
11,405 $325 Million
Q1 2021

Mar 30, 2023

BUY
$24.74 - $40.2 $186,960 - $303,791
7,557 Added 196.39%
11,405 $324,000
Q1 2021

May 14, 2021

SELL
$24.74 - $40.2 $94,927 - $154,247
-3,837 Reduced 99.71%
11 $325,000
Q4 2020

Jun 22, 2023

BUY
$21.68 - $51.61 $83,424 - $198,595
3,848 New
3,848 $109,000
Q3 2020

Jun 26, 2023

BUY
$18.07 - $31.84 $69,533 - $122,520
3,848 New
3,848 $118,000
Q3 2020

Mar 30, 2023

BUY
$18.07 - $31.84 $14,112 - $24,867
781 Added 25.46%
3,848 $118,000
Q3 2020

Nov 13, 2020

BUY
$18.07 - $31.84 $69,533 - $122,520
3,848 New
3,848 $119,000

Others Institutions Holding GBIO

About Generation Bio Co.


  • Ticker GBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,011,200
  • Market Cap $47.8M
  • Description
  • Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...
More about GBIO
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.